Floatz logo

Therapeutic Asset Ratings

169 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
CHLORHEXIDINE
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLCP2CCC (48)
Clindamycin
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLCP2CCC (48)
PAN-FGFR TYROSINE KINASE INHIBITOR JNJ-42756493
Advanced Solid Tumor
Janssen Research & Development, LLCP2CCC (48)
TACROLIMUS
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLCP2CCC (48)
Timolol
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLCP2CCC (48)
ZINC D-GLUCONATE (1:2)
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLCP2CCC (48)
SAFIMALTIB
Leukemia, Lymphocytic, Chronic, B-Cell
Janssen Research & Development, LLCP1CCC (48)
Amivantamab-Vmjw
Advanced or Metastatic Colorectal Cancer
Janssen Research & Development, LLCP1/2CCC (48)
Jnj-64251330
Adenomatous Polyposis Coli
Janssen Research & Development, LLCP1CC (47)
Jnj-79032421
Advanced Stage Solid Tumors
Janssen Research & Development, LLCP1CC (47)
Obinutuzumab
Multiple Myeloma
Janssen Research & Development, LLCP2CC (46)
Jnj-64264681
Lymphoma, Non-Hodgkin
Janssen Research & Development, LLCP1CC (46)
Prizloncabtagene Autoleucel
Lymphoma, Large B-Cell, Diffuse
Janssen Research & Development, LLCP1/2CC (45)
Immunoglobulin G4, anti-(human CD3 antigen) (recombinant human monoclonal JNJ-75348780 ?4-chain), disulfide with recombinant human monoclonal JNJ-75348780 ? chain, (229?126?),(232?129?)-bis(disulfide) with immunoglobulin, anti-(human sialic acid-binding Ig-like lectin 2) (recombinant human single-domain VHH fragment)
Leukemia, Lymphocytic, Chronic, B-Cell
Janssen Research & Development, LLCP1CC (44)
Jnj-64264681
Leukemia, Lymphocytic, Chronic, B-Cell
Janssen Research & Development, LLCP1CC (44)
Bleximenib
Acute Leukemias
Janssen Research & Development, LLCP1CC (43)
immunoglobulin (H-gamma1_L-kappa)_scFvkh-G1(h-CH2-CH3), anti-[Homo sapiens KLK2 (kallikrein-2, kallikrein related peptidase 2, kallikrein 2 prostatic) and anti-[Homo sapiens CD3E (CD3 epsilon, Leu-4)], Homo sapiens and humanized monoclonal antibody, bispecific, bivalent
Adenocarcinoma
Janssen Research & Development, LLCP1CC (43)
immunoglobulin (H-gamma1_L-kappa)_scFvkh-G1(h-CH2-CH3), anti-[Homo sapiens KLK2 (kallikrein-2, kallikrein related peptidase 2, kallikrein 2 prostatic) and anti-[Homo sapiens CD3E (CD3 epsilon, Leu-4)], Homo sapiens and humanized monoclonal antibody, bispecific, bivalent
Metastatic Hormone-sensitive Prostate Cancer
Janssen Research & Development, LLCP1CC (43)
Jnj-101556143
Metastatic Castration-resistant Prostate Neoplasms
Janssen Research & Development, LLCP1CC (43)
Jnj-101556143
Metastatic Hormone-sensitive Prostate Cancer
Janssen Research & Development, LLCP1CC (43)
Jnj-69086420
Adenocarcinoma
Janssen Research & Development, LLCP1CC (43)
Jnj-75276617
Acute Leukemias
Janssen Research & Development, LLCP1CC (43)
Jnj-89853413
Myelodysplastic Neoplasms
Janssen Research & Development, LLCP1CC (43)
Jnj-90009530
Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Janssen Research & Development, LLCP1CC (43)
Jnj-90189892
Myelodysplastic Neoplasms
Janssen Research & Development, LLCP1CC (43)
Showing 51 to 75 of 169 assets
PreviousPage 3 of 7Next